MERCK Kommanditgesellschaft auf Aktien
MRK.DE

$62.77 B
Marketcap
$144.10
Share price
Country
$-0.26
Change (1 day)
$184.56
Year High
$141.91
Year Low

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

marketcap

P/E ratio for MERCK Kommanditgesellschaft auf Aktien (MRK.DE)

P/E ratio as of 2023: 22.19

According to MERCK Kommanditgesellschaft auf Aktien's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.19. At the end of 2022 the company had a P/E ratio of 23.65.

P/E ratio history for MERCK Kommanditgesellschaft auf Aktien from 2002 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 22.19
2022 23.65
2021 32.31
2020 30.71
2019 34.70
2018 11.65
2017 15.05
2016 26.44
2015 34.93
2014 29.48
2013 23.51
2012 38.89
2011 26.63
2010 20.28
2009 37.60
2008 37.00
2007 5.36
2006 15.24
2005 20.14
2004 14.28
2003 27.40
2002 20.29